Salesforce Com, Inc.

Salesforce, Inc.

Bayer Pharmaceuticals Corporation

Bayer Healthcare LLC

Teddy Kite Joe

Liam Tomar Fontvieille Doyle

Andrew Ian Craven

Dhanapalan Nagarathnam

Jacques P Dumas

Wendy Lee

Robert Sibley

Ning Miao Su

Stephen Boyer

Harold C E Kluender

Zachary Dunn

Joseph Olsen

Julie A Dixon

Holia Hatoum-Mokdad

In accordance with disclosed embodiments, there are provided methods, systems, and apparatuses for aggregating social network feed information including, for example, means for receiving user activity data from one or more social networks; parsing the user activity data to render a plurality of targeting parameters culled from the user activity data; matching one or more of the plurality of targeting parameters with advertising conditions for a social media campaign, wherein the advertising conditions of the social media campaign are contextually relevant to the one or more targeting parameters matched; recommending the social media campaign via a user interface; receiving authorization to launch the social media campaign via input received at the user interface or automatically launching the social media campaign based on pre-defined parameters; and deploying the social media campaign to one or many social media networks. Other related embodiments are disclosed.

System and method for aggregating social network feed information

A technique allows a newsfeed item shown in a newsfeed of a social network to be easily promoted to another newsfeed in the social network. In a specific embodiment, the system receives a first user's promotion selection of an item displayed in a newsfeed of the first user. The item includes content provided by a second user. The first user is prompted to select a destination newsfeed. A selection of the destination newsfeed is received and the item is published on the destination newsfeed for a third user.

Fragmenting newsfeed objects

Systems and methods for fragmenting newsfeed objects

Substituted and pyridines and pyridazines having angiogenesis inhibiting activity and the generalized structural formula wherein the ring containing A, B, D, E, and L is phenyl or a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; Rand Rmay be defined independent substituents or together may be a ring-defining bridge; ring J may be an aryl, pyridyl, or cycloalkyl group; and G groups may be any of a variety of defined substituents. Pharmaceutical compositions containing these materials, and methods of treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermiability processes using these materials are also disclosed.

Substituted pyridines and pyridazines with angiogenesis inhibiting activity

Substituted and Fused pyridazines having angiogenesis inhibiting activity and the generalized structural formulawherein the ring containing A, B, D, E, and L is a nitrogen-containing heterocycle; groups X and Y may be any of a variety of defined linking units; Rand Rmay be defined independent substituents or together may be a ring-defining bridge; ring J may be an aryl, pyridyl, or cycloalkyl group; and G groups may be any of a variety of defined substituents. Pharmaceutical compositions containing these materials, and methods of treating a mammal having a condition characterized by abnormal angiogenesis or hyperpermiability processes using these materials are also disclosed.

Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity

Growing community of inventors

San Francisco, CA, United States of America

Teddy Kite Joe